Our CTO, Luke Pase, will join the conference and take part in a panel discussing the next chapter for gene editing in allogeneic cell therapy development. Reach out if you would like to connect.
Press release Apr 7, 2022Renowned Immunotherapy Expert Dr. Michael Kalos joins Anocca’s Scientific Advisory Board
Södertälje, Sweden, 7th April 2022 – Anocca, a biotechnology company using its precision biology platforms …
Press release Feb 22, 2022Anocca Appoints New Senior Management Roles and Expands Scientific Teams
Södertälje, Sweden, February 22, 2022 – Anocca AB, a pioneer in T cell immunotherapy, today …
Press release Sep 8, 2021Anocca appoints Jacob Michlewicz as CFO
Södertälje, Sweden, 8 September 2021 – Anocca AB, a leader in unlocking the potential of …